What ImPACT Applications does

ImPACT Applications, Inc. is a private cognitive testing company that develops FDA-cleared Class II medical device software for computerized neurocognitive assessment, primarily focused on concussion identification, management, and recovery tracking. Founded in 2002 and headquartered in Itasca, Illinois, the company operates as a subsidiary of Riverside Insights. Its product portfolio centers on the flagship ImPACT test (ages 12-80), with sub-brands including ImPACT Pediatric (ages 5-11), ImPACT Quick Test (sideline assessment), ImPACT Balance (postural stability via UpRight integration), and the Cognitive Impairment Screener for broader neurocognitive screening. Products are administered through the ImPACT Toolkit mobile app (iPad) and managed via the ImPACT Customer Center web portal, with patient-facing functionality delivered through the free ImPACT Passport mobile app. The platform has administered 27+ million tests globally and is supported by 750+ peer-reviewed studies, positioning ImPACT as the longest-standing FDA-cleared concussion management device.

The company serves four primary customer segments: healthcare providers (hospitals, clinics, sports medicine practices, urgent care), schools and sports teams (high schools, universities, professional and amateur leagues), workers' compensation programs, and individual consumers. Revenue is generated through multiple streams: tiered annual subscription packages for healthcare (Basic, Plus, Premium) and schools/teams (Packages 1-4), per-test pricing for individuals ($12.50/test) and large school districts ($2.85/test at 10,000+ students volume), training and credential programs (ITAT, ITOT, ITPT, CME courses), and tools supporting CPT code reimbursement for healthcare providers.

Go-to-market combines enterprise field sales for large healthcare organizations and school districts, inside sales for mid-market accounts, product-led growth via baselinetesting.com for individual baseline testing, and a global channel partner network covering Canada (PRIVIT), Australia and South Africa (HeadSmart), Middle East and North Africa (ConnecME Education, 30 countries), and Ireland (UPMC, 32 counties). Distribution is further extended through integration partnerships with SportsEngine, HeadCheck Health, Player's Health, and insurance partnerships with Utica National. The company maintains extensive regulatory and privacy compliance including FDA, Health Canada, Australian TGA, CE marking, ISO 13485, MDSAP, HIPAA, GDPR, CCPA, FERPA, COPPA, and PIPEDA.

Name

ImPACT Applications

Legal name

ImPACT Applications, Inc.

Website

https://impacttest.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

ImPACT Applications is a cognitive testing company that develops FDA-cleared computerized neurocognitive assessment tools for concussion management and cognitive screening. It serves healthcare providers, schools, sports teams, and individuals via subscription platforms, mobile apps, and a global channel partner network.

Ownership category

akta.pro rank

Product category

Concussion Management Software

NAICS

Testing Laboratories and Services (54138)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industries

Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

Keywords

• Concussion management software
• Neurocognitive assessment tools
• FDA-cleared medical devices
• Computerized cognitive testing
• Baseline concussion screening

Headquarters

HQ city

Coralville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Subscription-based Test Packages: Healthcare organizations purchase subscription packages (Basic, Plus, Premium) with bundled post-injury and baseline tests. Schools purchase annual subscription packages with tiered baseline and post-injury test allocations.
2. Per-Test Pricing: Individual baseline tests sold at $12.50 per test for smaller school/team packages. Volume discounts for large school districts ($2.85/test for 10,000+ students). Reimbursement available via CPT code 96116.
3. Cognitive Impairment Screener: CIS sold at $12 per test for healthcare providers, reimbursable via CPT billing codes.
4. Training and Credential Programs: Online credential programs (ITAT, ITOT, ITPT) for athletic trainers, occupational therapists, and physical therapists. CME-accredited courses for physicians. Free onboarding and billing/coding courses for practice staff.
5. CPT Reimbursement Support: Tools and documentation to support healthcare providers in obtaining reimbursement through CPT billing codes, creating value-based revenue opportunity for customers.

Pricing tiers

Go-to-market motion5 records

Distribution channels11 records

Marketing channels12 records

Core offering

ImPACT Applications develops and sells FDA-cleared computerized neurocognitive assessment software (medical devices) for concussion identification, management, and recovery tracking. Its products—ImPACT, ImPACT Pediatric, ImPACT Quick Test, and Balance by UpRight—measure memory, attention, visual/verbal problem solving, and postural stability to support return-to-activity decisions for healthcare providers, schools, and sports organizations. The platform is complemented by the ImPACT Toolkit administrator app, the ImPACT Passport patient app, and the Cognitive Impairment Screener for broader neurocognitive evaluation.

Product overview

ImPACT Applications offers a comprehensive suite of concussion assessment and management tools under the ImPACT platform umbrella. The core offering is ImPACT, a computerized neurocognitive assessment tool for ages 12-80, with a pediatric-specific version (ImPACT Pediatric) for ages 5-11 and an iPad-optimized variant (ImPACT for iPad) for ages 12-59. ImPACT Quick Test provides a rapid iPad-based sideline assessment for removal-from-activity decisions. These products are administered via the ImPACT Toolkit mobile app or through the ImPACT Customer Center web portal, and are complemented by the ImPACT Balance assessment and Balance by UpRight integration for postural stability measurement, all accessible through the free ImPACT Passport mobile app for patients. The Cognitive Impairment Screener (CIS) extends the portfolio beyond concussion to general cognitive impairment screening. The company has released major version updates (Version 4 in 2021, Version 5 in 2025) and maintains the ImPACT Customer Center as the centralized platform for clinical reporting and account management across US, Canada, Europe, and international regions.

Differentiator

Problem solved

Functional benefit

Brands

• ImPACT: Flagship computerized neurocognitive concussion assessment tool for ages 12-80.
• ImPACT Pediatric
• ImPACT Quick Test
• ImPACT Passport
• Cognitive Impairment Screener (CIS)

Products and services

• ImPACT Flagship computerized battery of neurocognitive tests assessing memory, attention span, visual and verbal problem solving, and reaction time to aid concussion management and return-to-activity decisions for individuals aged 12-80.
• ImPACT Pediatric Computerized neurocognitive assessment aid for children ages 5-11, administered through the ImPACT Toolkit app on iPad, designed specifically for pediatric concussion evaluation.
• ImPACT Quick Test FDA-cleared iPad-based brief sideline assessment tool that captures objective cognitive data at the point of care to help determine if a patient should be removed from activity due to suspected concussion.
• ImPACT Balance (Balance by UpRight) FDA-cleared balance assessment that uses smartphone sensors to measure postural stability, integrated into the ImPACT Platform and accessible through the ImPACT Passport app, providing objective balance data for concussion evaluation and recovery monitoring.
• ImPACT Passport Free iPhone and Android concussion care app allowing patients to store their unique 12-digit ImPACT Passport ID, record symptoms, find local healthcare providers, access the Balance assessment, and securely share data with clinicians.
• ImPACT Toolkit Mobile app enabling administrators to administer ImPACT, ImPACT Pediatric, and ImPACT Quick Test both online and offline on iPad, and to record BESS and VOMS assessment scores after ImPACT Quick Test completion.
• ImPACT for iPad iPad-optimized version of the flagship ImPACT computerized cognitive test featuring iPad-specific normative data for individuals aged 12-59, FDA-cleared for aiding in concussion diagnosis.
• Cognitive Impairment Screener (CIS) Brief computerized neurocognitive screening tool combining a 16-question psychiatric questionnaire with two neurocognitive test modules measuring visual memory, verbal memory, and performance speed, used to identify individuals ages 18-80 who need further assessment for neurocognitive deficits and mental illnesses. Administered remotely or in-person in 10 minutes.
• ImPACT Version 5 Latest version of the flagship ImPACT computerized cognitive test featuring customizable demographics, randomized word lists in the word memory module, and a refreshed interface; results remain fully comparable with Version 4.

Quantifiable outcome

• 27+ million tests administered globally as of June 2026
• +6 more outcomes

Named customers28 records

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature10 records

Partnerships

14 partnerships are on record, tiered core and minor.

• UpRight SciencecoreTechnology or Integration · 22 June 2026Integration of Balance by UpRight FDA-cleared balance measurement technology into ImPACT Platform. Uses smartphone sensors to measure postural stability. Provides holistic brain health assessment for student athletes from baseline to post-concussion readings.
• UPMC (Ireland)coreChannel Partner/ Reseller/ Distributor · 20 January 2023UPMC partnered with Irish sporting organizations (GAA, Ladies Gaelic Football Association, Camogie Association, Gaelic Players Association) to deliver nationwide ImPACT testing across 32 counties in Ireland. Testing conducted remotely and in UPMC clinics by certified ImPACT specialists.
• Aptiva HealthminorChannel Partner/ Reseller/ Distributor · 20 May 2022Launched Concussion & Sports Medicine Institute in Louisville, KY to increase access to concussion care in underserved rural Kentucky areas. Offers same-day appointments and telemedicine using FDA-cleared ImPACT testing.
• ConnecME EducationcoreChannel Partner/ Reseller/ Distributor · 7 June 2021Exclusive partnership expanding ImPACT reach to 30 new countries in Middle East and North Africa regions. Schools, sports leagues, and insurance companies in MENA now have access to ImPACT through ConnecME as local resource.
• Integrated Medical Case Solutions (IMCS)coreStrategic or Co-development Partner · 31 July 2020Partnership to support evaluation and treatment of workplace concussions. IMCS trained their global network of 1,200+ psychologists across all 50 states to incorporate ImPACT as part of comprehensive concussion evaluation protocol and return to work treatment.
• University of St. Augustine for Health SciencescoreStrategic or Co-development Partner · 11 January 2020Five-year partnership providing education focused on concussion care and rehab. Developed ImPACT Trained Athletic Trainer (ITAT), Occupational Therapist (ITOT), and Physical Therapist (ITPT) credentials through Master of Health Science programs.
• SportsEngine, Inc.minorChannel Partner/ Reseller/ Distributor · 8 November 2019Partnership to expand availability of ImPACT baseline testing to help identify and manage youth sports concussions. Addresses CDC finding that falls are main cause of concussions.
• HeadSmart Concussion ProgrammeminorChannel Partner/ Reseller/ Distributor · 26 September 2019HeadSmart is leading distributor of online concussion testing in Australia and South Africa. Partnership makes ImPACT available to athletes at all levels in these regions.
• Player's HealthminorChannel Partner/ Reseller/ Distributor · 21 September 2019Risk management firm specializing in amateur sports. Partnership provides concussion testing protocols to help sports organizations and parents monitor concussions in athletes.
• HeadCheck HealthminorChannel Partner/ Reseller/ Distributor · 14 September 2019Mobile app and web-based technology company specializing in concussion safety and protocol management. Delivers ImPACT assessment tools to sports organizations and medical professionals through HeadCheck platform.
• PRIVITminorChannel Partner/ Reseller/ Distributor · 7 September 2019Software company specializing in secure collection and management of health information. Now offers ImPACT baseline and post-injury testing along with concussion care training to healthcare providers in Canada.
• Utica National Insurance GroupminorChannel Partner/ Reseller/ Distributor · 25 August 2019Insurance company offering ImPACT cognitive baseline and post-injury concussion testing to member school policyholders. Addresses both safety and liability concerns for schools.
• FDA and International Regulatory BodiescoreOthers · 31 October 2018Received regulatory clearance for at-home ImPACT baseline testing from FDA, Health Canada, and other regulatory bodies, enabling telemedicine and home-based concussion care.
• Riverside InsightscoreStrategic or Co-development PartnerParent company. ImPACT Applications is part of Riverside Insights, an assessment company specializing in research-based tools that help elevate learning potential from early childhood and beyond.

Scale indicators15 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• HeadCheck Health: HeadCheck Health is a mobile and web-based concussion management platform that delivers ImPACT itself as a partner, but also offers its own end-to-end protocol management. It directly overlaps with ImPACT Applications in sports organizations and medical professionals seeking integrated concussion workflows.
• SyncThink: SyncThink's Eye-Sync technology uses VR-based eye-tracking to assess concussion and balance impairment, competing with ImPACT's neurocognitive and now Balance by UpRight platform. Both target clinical concussion assessment with FDA-cleared digital tools for sports medicine and military use.
• Sway Medical: Sway Medical offers FDA-cleared mobile balance and cognitive assessment for concussion, directly competing with ImPACT's Balance by UpRight integration. Both target athletic trainers, schools, and clinical providers with smartphone-based concussion screening tools.
• King-Devick Technologies: King-Devick is a computerized sideline concussion screening tool competing directly with ImPACT Quick Test in sports and athletic training markets. Both serve athletic trainers, schools, and sports medicine providers with objective, FDA-aligned cognitive screening solutions.
• C3 Logix: C3 Logix is a multi-modal concussion assessment platform combining neurocognitive, balance, and vestibular testing, directly competing with ImPACT's integrated platform (cognitive + Balance by UpRight). It targets the same clinical and sports medicine customer segments.
• Biocore: Biocore provides concussion research, protocol design, and testing services for military, sports, and clinical applications. It overlaps with ImPACT in clinical concussion evaluation tools and evidence-based assessment protocols for athletic and military organizations.

Emerging players

• Prevent Biometrics: Prevent Biometrics makes head-impact mouthguard sensors that quantify head impacts, addressing concussion risk monitoring. While methodologically different from ImPACT's cognitive testing, both compete for the same school and sports organization concussion management budgets.
• Quadrant Biosciences: Quadrant Biosciences offers saliva-based biomarker concussion diagnostics (Clarifi) that complement or compete with neurocognitive testing in clinical and sports concussion workflows. Both pursue objective, FDA-aligned concussion assessment but Quadrant uses molecular diagnostics rather than cognitive batteries.

Others

• Riverside Insights: Riverside Insights is ImPACT Applications' parent company, providing K-12 educational and clinical assessments. While not a direct competitor, its portfolio strategy, capital allocation, and distribution synergies directly shape ImPACT's growth trajectory.

Regional players

• UPMC Sports Medicine: UPMC operates one of the largest concussion care clinical networks in the U.S. and partners with ImPACT in Ireland. UPMC represents both a partner and a channel competitor — its clinical programs can substitute for or amplify ImPACT's software offering depending on the buyer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/impacttest
• YouTubeyoutube.com/user/ImPACTApplications
• Facebookfacebook.com/impact.applications

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ImPACT Applications